Search research articles
Contact Us
Filters
Showing results (121-130 of 180) with videos related to
Page
of 18
Sort By:
European Journal of Human Genetics : EJHG
|
November 11, 2011
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome
Franck Bourdeaut, Sandrine Ferrand, Laurence Brugières, et al.
European Radiology
|
April 24, 2020
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma
Alison Dormieux, Laura Mezquita, Paul Henry Cournede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin
Eve Maubec, Peter Petrow, Isabelle Scheer-Senyarich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2022
Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials
Patricia Martin-Romano, Leo Colmet-Daage, Daphne Morel, et al.
JCO Precision Oncology
|
September 11, 2020
Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non-Small-Cell Lung Cancer
Jordi Remon, Ludovic Lacroix, Cecile Jovelet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2011
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1
Jean Philippe Arnault, Christine Mateus, Bernard Escudier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2019
Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression
Mihaela Aldea, Lizza Hendriks, Laura Mezquita, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report
Diego Enrico, Ludovic Lacroix, Jeanne Chen, et al.
JCO Precision Oncology
|
October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
JCO Precision Oncology
|
May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
Julieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 180) with videos related to
Sort By:
Page
of 18
European Journal of Human Genetics : EJHG
|
November 11, 2011
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome
Franck Bourdeaut, Sandrine Ferrand, Laurence Brugières, et al.
European Radiology
|
April 24, 2020
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma
Alison Dormieux, Laura Mezquita, Paul Henry Cournede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin
Eve Maubec, Peter Petrow, Isabelle Scheer-Senyarich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2022
Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials
Patricia Martin-Romano, Leo Colmet-Daage, Daphne Morel, et al.
JCO Precision Oncology
|
September 11, 2020
Real-World Utility of an Amplicon-Based Next-Generation Sequencing Liquid Biopsy for Broad Molecular Profiling in Patients With Advanced Non-Small-Cell Lung Cancer
Jordi Remon, Ludovic Lacroix, Cecile Jovelet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2011
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1
Jean Philippe Arnault, Christine Mateus, Bernard Escudier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2019
Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System Progression
Mihaela Aldea, Lizza Hendriks, Laura Mezquita, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report
Diego Enrico, Ludovic Lacroix, Jeanne Chen, et al.
JCO Precision Oncology
|
October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
JCO Precision Oncology
|
May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
Julieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
Page
of 18